ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Quantitative pathological lymph node parameters in head and neck squamous cell carcinoma: a comprehensive analysis of complementary prognostic value in clinically relevant subgroups.
Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeQuantitative pathological lymph node parameters (qpLNP), i.e. lymph node yield (LNY), lymph node ratio (LNR), and weighted lymph node ratio (WLNR), are potential prognostic markers in head and neck squamous cell carcinoma (HNSCC). Incorporation into post-operative staging may help to direct more precise adjuvant treatment regimens. Available data warrant more detailed subgroup analyses, we therefore evaluated their prognostic value with particular attention to neck dissection laterality, pN0 disease, and patients without recommendation for adjuvant therapy.
methodsWe performed a retrospective analysis of 410 surgically treated HNSCC patients from a single tertiary center (2010-2020). Data-derived cutoffs were determined by recursive partitioning. Overall survival was analyzed using Kaplan-Meier estimates, log-rank tests, and multivariable Cox regression. 67 patients with HPV-associated oropharyngeal carcinoma were analyzed separately.
resultsIn 343 patients with HPV-unrelated HNSCC, LNY, LNR, and WLNR were independently associated with overall survival on multivariable analysis (LNY: HR 1.58, p=0.012; LNR: HR 1.77, p=0.026; WLNR: HR 2.30, p<0.001). Discriminative performance increased from LNY (C-index 0.55) to LNR (0.59) to WLNR (0.61). Prognostic signal was primarily driven by the ipsilateral and not the contralateral neck. LNY (HR 1.92, p=0.044) and WLNR (HR 2.31, p=0.038) showed prognostic value in patients without adjuvant therapy, and LNY remained independently prognostic in node-negative patients on multivariable analysis (HR 1.88, p=0.027). Site-specific analyses in patients with HPV-unrelated oropharyngeal carcinoma and oral cavity carcinoma treated with bilateral neck dissection confirmed independent prognostic value for LNY and WLNR in both subgroups. In HPV-associated oropharyngeal carcinoma, qpLNP held no prognostic value. Here, extranodal extension was the dominant prognostic factor.
conclusionLNY, LNR, and WLNR provide complementary prognostic information in HPV-unrelated HNSCC. The validity of LNY in node-negative patients emphasizes its value as a quality control parameter for surgery while WLNR's performance in patients without adjuvant therapy suggests additional value in patient stratification for adjuvant treatment.
Indexed as
Identifiers
42900200What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.